Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

303 Views

047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Treatment

(539) Efficacy in Multiple SARS-CoV-2 Animal Models Supports Phase 3 Dose Selection for Obeldesivir

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Jared Pitts, PhD (he/him/his)

Senior Research Scientist
Gilead Sciences, Inc.
Foster City, California, United States

Co-Author(s)

DB

Darius Babusis, BA

Gilead Sciences, Inc.
Foster City, California, United States
RH

Rita Humeniuk, PhD

Gilead Sciences, Inc.
Foster City, California, United States
DM

David Martinez, PhD

University of North Carolina
Chapel Hill, North Carolina, United States
RC

Robert M. Cox, PhD

Institute for Biomedical Sciences, Georgia State University
Atlanta, Georgia, United States
AS

Alexandra Schäfer, PhD

University of North Carolina
Chapel Hill, North Carolina, United States
NR

Nicholas C. Riola, BS

Gilead Sciences, Inc.
Foster City, California, United States
JF

Joy Feng, PhD

Gilead Sciences, Inc.
Foster City, California, United States
VD

Venice Du Pont, PhD

Gilead Sciences, Inc.
Foster City, California, United States
OA

Olena Anoshchenko, PhD

Gilead Sciences, Inc.
Foster City, California, United States
MV

Meghan Vermillion, DVM, PhD

Lovelace Biomedical Research Institute
Albuquerque, New Mexico, United States
MA

Mazin Abdelghany, MD

Gilead Sciences, Inc.
Foster City, California, United States
RH

Robert H. Hyland, DPhil

Gilead Sciences, Inc.
Foster City, California, United States
SG

Sandhya Girish, PhD

Gilead Sciences, Inc.
Foster City, California, United States
TS

Timothy P. Sheahan, PhD

University of North Carolina
Chapel Hill, North Carolina, United States
RP

Richard K. Plemper, PhD

Institute for Biomedical Sciences, Georgia State University
Atlanta, Georgia, United States
RB

Ralph S. Baric, PhD

Institute for Biomedical Sciences, Georgia State University
Atlanta, Georgia, United States
TC

Tomas Cihlar, PhD

Vice President of Biology
Gilead Sciences, Inc.
Foster City, California, United States
JL

Joe Llewellyn, PharmD (he/him/his)

Clinical Development
Gilead Sciences, Inc.
Foster City, California, United States
HW

Helen Winter, PhD

Gilead Sciences, Inc.
Foster City, California, United States
RB

Roy Bannister, PhD

Gilead Sciences, Inc.
Foster City, California, United States
RS

Raju Subramanian, PhD

Gilead Sciences, Inc.
Foster City, California, United States
RM

Richard L. Mackman, PhD

Gilead Sciences, Inc.
Foster City, California, United States
JB

John P. Bilello, PhD

Gilead Sciences, Inc.
Foster City, California, United States